Abstract | PURPOSE: We sought to evaluate the effectiveness and the complications related to the use of Ethisorb (resorbable alloplastic material) in the reconstruction of orbital floor fractures. PATIENTS AND METHODS: We retrospectively reviewed the charts of all patients who underwent orbital floor fracture reconstruction with Ethisorb since 2001. We only included patients with a minimum follow-up of 3 months. The following data were recorded for every patient: age, gender, cause of trauma, time from trauma to surgery, signs and symptoms, concomitant ocular injuries, radiographic analysis, pertinent intraoperative findings (including the type of approach), follow-up time, and postoperative complications. RESULTS: Eighty-seven patients were included in the study. Twenty-one patients (24.1%) experienced postoperative complications. Of these, only 3 patients (3.4%) had permanent complications directly related to the Ethisorb membrane ( diplopia, enophthalmos). Two of these patients required revision surgery and are discussed in the article. CONCLUSIONS: The results of our study demonstrate the effectiveness of Ethisorb in the repair of small-to-moderate orbital floor fracture defects (up to a maximum size of 2 x 2 cm).
|
Authors | Pascal Büchel, Akram Rahal, Ichiro Seto, Tateyuki Iizuka |
Journal | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
(J Oral Maxillofac Surg)
Vol. 63
Issue 5
Pg. 646-50
(May 2005)
ISSN: 0278-2391 [Print] United States |
PMID | 15883939
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- Bone Substitutes
- Ethisorb
- Polyesters
- Polyglycolic Acid
- Polydioxanone
- Polyglactin 910
|
Topics |
- Absorbable Implants
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Bone Substitutes
(therapeutic use)
- Child
- Diplopia
(therapy)
- Enophthalmos
(surgery)
- Female
- Humans
- Male
- Middle Aged
- Orbit
(surgery)
- Orbital Fractures
(surgery)
- Polydioxanone
(therapeutic use)
- Polyesters
(therapeutic use)
- Polyglactin 910
(therapeutic use)
- Polyglycolic Acid
(therapeutic use)
- Postoperative Complications
- Retreatment
- Retrospective Studies
|